Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Gonadotropin-releasing Hormone
Total 0 results
Nothing found
Sponsors and Collaborators
GFI
Kupfer, David J., M.D.
Agency for Science, Technology and Research
Hospital Durand, Argentina
Korean Society of Spine Surgery
Alma Lasers Inc.
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Neurophth Therapeutics Inc
Aptis Medical
RMIT University, Melbourne, Australia
Hospital ASEPEYO Sant Cugat
Everett Meyer
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Mª Victoria Maestre Sanchez
iCAD
Eurofins Genoma
ASST Cremona, Cremona
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Nacuity Pharmaceuticals, Inc.
Apollo Neuroscience, Inc.
View Full List
Medical Conditions
Disorder of Fluid Balance
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Fever
Major Liver Surgery
Corneal Cross-Linking
T-LGL Leukemia
Scleredema
Dienogest
Luteal Phase Support
The Strength Properties of the Aorta in Vitro
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
RISS Stage III Plasma Cell Myeloma
Chronic Constipation Symptoms
Metachronous Adenoma
Rheumatoid Arthritis(RA)
Immune-Mediated Inflammatory Disease
Gastric Cancer Stage IIIB-IIIC
Treatment Decisions
Splenic Trauma
Recurrent Clear Cell Sarcoma of Soft Tissue
View Full List
Drug Interventions
Camptosar
Fospropofol disodium, propofol
Capecitabine and IMRT (if randomized to this arm)
Olopatadine
MLN2480
Standard of care (SOC) for COVID-19
PD-1/PD-L1 inhibitor
GLPG1837 multiple ascending doses
Oxycodone/acetaminophen 5/325 mg
Intravenous Formulation of PD-0332991
Capecitabine/cisplatin
Anticholinergic
Desvenlafaxine
OnabotulinumtoxinA
Midazolam
Letrozole
Intravenous deferiprone
TPN-101
RDX227675
THC
View Full List
CROs by country
Contract Research Organizations in Austria
Contract Research Organizations in Bahrain
Contract Research Organizations in Belgium
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Cameroon
Contract Research Organizations in Chile
Contract Research Organizations in Cyprus
Contract Research Organizations in Gambia
Contract Research Organizations in India
Contract Research Organizations in Luxembourg
Contract Research Organizations in Paraguay
Contract Research Organizations in Senegal
Contract Research Organizations in Taiwan
CRO list by country
CROs in Trinidad & Tobago
SGS
All CROs in Trinidad & Tobago
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe